Reinikainen P - Search Results

1

Radium-223 dichloride treatment in metastatic castration-resistant prostate cancer in Finland: A real-world evidence multicenter study.

Hyväkkä A, Kääriäinen OS, Utriainen T, Löyttyniemi E, Mattila K, Reinikainen P, Sormunen J, Jääskeläinen M, Auvinen P, Minn H, Sundvall M. Hyväkkä A, et al. Among authors: reinikainen p. Cancer Med. 2023 Feb;12(4):4064-4076. doi: 10.1002/cam4.5262. Epub 2022 Sep 26. Cancer Med. 2023. PMID: 36156455 Free PMC article.

2

Safer and More Convenient Modern Curative Radiotherapy for Patients With Early Prostate Cancer.

Reinikainen P, Lehtinen I, Luukkaala T, Kellokumpu-Lehtinen PL. Reinikainen P, et al. Anticancer Res. 2024 Jan;44(1):139-150. doi: 10.21873/anticanres.16796. Anticancer Res. 2024. PMID: 38159980 Clinical Trial.

3

Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer.

Lehtonen M, Heiskanen L, Reinikainen P, Kellokumpu-Lehtinen PL. Lehtonen M, et al. Among authors: reinikainen p. BMC Cancer. 2020 Apr 15;20(1):324. doi: 10.1186/s12885-020-06812-6. BMC Cancer. 2020. PMID: 32295542 Free PMC article.

4

Reinikainen P, Lehtonen M, Lehtinen I, Luukkaala T, Sintonen H, Kellokumpu-Lehtinen PL. Reinikainen P, et al. Clin Genitourin Cancer. 2023 Feb;21(1):146-154. doi: 10.1016/j.clgc.2022.07.013. Epub 2022 Aug 3. Clin Genitourin Cancer. 2023. PMID: 36038484 Free article.

5

Radiation-induced prostate swelling during SBRT of the prostate.

Vanhanen A, Reinikainen P, Kapanen M. Vanhanen A, et al. Among authors: reinikainen p. Acta Oncol. 2022 Jun;61(6):698-704. doi: 10.1080/0284186X.2022.2062682. Epub 2022 Apr 17. Acta Oncol. 2022. PMID: 35435111 Clinical Trial.

6

Acute Side-effects of Different Radiotherapy Treatment Schedules in Early Prostate Cancer.

Reinikainen P, Kapanen M, Luukkaala T, Kellokumpu-Lehtinen PL. Reinikainen P, et al. Anticancer Res. 2022 May;42(5):2553-2565. doi: 10.21873/anticanres.15733. Anticancer Res. 2022. PMID: 35489724

7

Dynamic Contrast-Enhanced Imaging as a Prognostic Tool in Early Diagnosis of Prostate Cancer: Correlation with PSA and Clinical Stage.

Wu X, Reinikainen P, Kapanen M, Vierikko T, Ryymin P, Kellokumpu-Lehtinen PL. Wu X, et al. Among authors: reinikainen p. Contrast Media Mol Imaging. 2018 Sep 19;2018:3181258. doi: 10.1155/2018/3181258. eCollection 2018. Contrast Media Mol Imaging. 2018. PMID: 30327584 Free PMC article. Clinical Trial.

8

Correlation between apparent diffusion coefficient value on diffusion-weighted MR imaging and Gleason score in prostate cancer.

Wu X, Reinikainen P, Vanhanen A, Kapanen M, Vierikko T, Ryymin P, Hyödynmaa S, Kellokumpu-Lehtinen PL. Wu X, et al. Among authors: reinikainen p. Diagn Interv Imaging. 2017 Jan;98(1):63-71. doi: 10.1016/j.diii.2016.08.009. Epub 2016 Sep 27. Diagn Interv Imaging. 2017. PMID: 27687831 Free article.

9

Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer.

Wu X, Reinikainen P, Kapanen M, Vierikko T, Ryymin P, Kellokumpu-Lehtinen PL. Wu X, et al. Among authors: reinikainen p. Anticancer Res. 2017 Sep;37(9):5027-5032. doi: 10.21873/anticanres.11917. Anticancer Res. 2017. PMID: 28870929

10

Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI).

Wu X, Reinikainen P, Kapanen M, Vierikko T, Ryymin P, Kellokumpu-Lehtinen PL. Wu X, et al. Among authors: reinikainen p. Diagn Interv Imaging. 2019 Nov;100(11):699-708. doi: 10.1016/j.diii.2019.06.003. Epub 2019 Jun 27. Diagn Interv Imaging. 2019. PMID: 31257114 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page